Epidermal growth factor receptor mutation testing in Thailand: A cost-utility analysis
Objective: To evaluate the cost utility of epidermal growth factor receptor (EGFR) testing plus first-line gefitinib treatment in patients with activating EGFR mutations in Thailand. Methods: The study used a decision tree model considering the provider's perspective. Direct medical costs were...
Saved in:
Main Authors: | Unchalee Permsuwan, Narawadee Niamhun, Narumon Tanatip, Sumitra Thongprasert |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84897471037&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/53467 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Epidermal growth factor receptor mutation testing in Thailand: A cost-utility analysis
by: Unchalee Permsuwan, et al.
Published: (2018) -
Cost-Utility Analysis of First-Line Pemetrexed Plus Cisplatin in Non-Small Cell Lung Cancer in Thailand
by: Unchalee Permsuwan, et al.
Published: (2020) -
Cost-utility analysis of home-based care for treatment of Thai hemophilia A and B
by: Oraluck Pattanaprateep, et al.
Published: (2018) -
Cost-Utility Analysis of Erythropoietin for Anemia Treatment in Thai End-Stage Renal Disease Patients with Hemodialysis
by: Tanita Thaweethamcharoen, et al.
Published: (2018) -
Resource utilization and direct medical costs of chronic hepatitis C in Thailand: A heavy but manageable economic burden
by: Satawat Thongsawat, et al.
Published: (2018)